Mahadevia Ankit 4
4 · Spero Therapeutics, Inc. · Filed Aug 29, 2024
Insider Transaction Report
Form 4
Mahadevia Ankit
Director
Transactions
- Sale
Common Stock
2024-08-27$1.35/sh−5,912$7,981→ 759,085 total
Footnotes (1)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on August 26, 2021.